Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Latin America Hemostasis Diagnostics Market: By Product Type, By Test Type, By Technology, By End-User ), and Country
Latin America Hemostasis Diagnostics Market: By Product Type, By Test Type, By Technology, By End-User ), and Country
Latin America Hemostasis Diagnostics Market size was valued at US$ x million in 2023 and is poised to grow at a CAGR of x% during the forecast period 2024-2030. This report studies Latin America Hemostasis diagnostics Market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers, and service providers engaged.
Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as stopping or slowing the blood flow from damaged blood vessel. During hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects.
Increase in the prevalence of hemophilia in Latin America region (according to World Federation of Hemophilia Global Survey 2010, approximately 10,065 hemophilia cases were observed in Brazil), economic growth, and expansion of business by market players into Latin America region are anticipated to fuel the market. However, high cost of advanced hemostasis products, and regulatory bottlenecks for the test approvals are expected to hamper the growth of hemostasis diagnostics market.
Brazil hemostasis diagnostics market is growing due to increase in the prevalence of hemophilia disease, development of healthcare infrastructure, and adoption of newer tests are anticipated to propel the market. Mexico hemostasis diagnostics market is growing due to increase in the prevalence of blood clotting diseases and launching of newer products are expected to propel the market growth over forecast years.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Product Type |
|
|
By Test Type |
|
|
By Technology |
|
|
By End User |
|
Download Free Sample Report
2023 is the base year and 2030 is the forecast year.
The Latin America hemostasis diagnostics market coverage are the Brazil, Mexico, Argentina
The Latin America hemostasis diagnostics market key players are the F. Hoffmann-La Roche Ltd., Sysmex Corporation, Abbott Laboratories, Alere Inc., Nihon Kohden Corporation, Siemens Healthineers, Grifols S.A, Beckman Coulter, Inc.
| 1.Executive Summary |
| 2.Latin America Hemostasis Diagnostics Market Introduction |
| 2.1.Latin America Hemostasis Diagnostics Market - Taxonomy |
| 2.2.Latin America Hemostasis Diagnostics Market - Definitions |
| 2.2.1.Product Type |
| 2.2.2.Test Type |
| 2.2.3.Technology |
| 2.2.4.Country |
| 3.Latin America Hemostasis Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Latin America Hemostasis Diagnostics Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Latin America Hemostasis Diagnostics Market By Product Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Systems |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Consumables |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Point-of-Care Testing Devices |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 6.Latin America Hemostasis Diagnostics Market By Test Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Fibrinogen Test |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Activated Clotting Time |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Platelet Function |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Prothrombin Time |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Heparin & Protamine Dose-Response Test For ACT |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 6.6. Activated Partial Thromboplastin Time |
| 6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.6.3. Market Opportunity Analysis |
| 6.7. Anti-Factor Xa |
| 6.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.7.3. Market Opportunity Analysis |
| 6.8. Other Coagulation Tests |
| 6.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.8.3. Market Opportunity Analysis |
| 7.Latin America Hemostasis Diagnostics Market By Technology, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Optical |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Mechanical |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Electrochemical |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Others |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 8.Latin America Hemostasis Diagnostics Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. Brazil |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Mexico |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Rest of LA |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9.Brazil Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Product Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Systems |
| 9.1.2.Consumables |
| 9.1.3.Point-of-Care Testing Devices |
| 9.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Fibrinogen Test |
| 9.2.2.Activated Clotting Time |
| 9.2.3.Platelet Function |
| 9.2.4.Prothrombin Time |
| 9.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 9.2.6.Activated Partial Thromboplastin Time |
| 9.2.7.Anti-Factor Xa |
| 9.2.8.Other Coagulation Tests |
| 9.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Optical |
| 9.3.2.Mechanical |
| 9.3.3.Electrochemical |
| 9.3.4.Others |
| 10.Mexico Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Systems |
| 10.1.2.Consumables |
| 10.1.3.Point-of-Care Testing Devices |
| 10.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Fibrinogen Test |
| 10.2.2.Activated Clotting Time |
| 10.2.3.Platelet Function |
| 10.2.4.Prothrombin Time |
| 10.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 10.2.6.Activated Partial Thromboplastin Time |
| 10.2.7.Anti-Factor Xa |
| 10.2.8.Other Coagulation Tests |
| 10.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Optical |
| 10.3.2.Mechanical |
| 10.3.3.Electrochemical |
| 10.3.4.Others |
| 11.Rest of LA Hemostasis Diagnostics Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Systems |
| 11.1.2.Consumables |
| 11.1.3.Point-of-Care Testing Devices |
| 11.2. Test Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Fibrinogen Test |
| 11.2.2.Activated Clotting Time |
| 11.2.3.Platelet Function |
| 11.2.4.Prothrombin Time |
| 11.2.5.Heparin & Protamine Dose-Response Test For ACT |
| 11.2.6.Activated Partial Thromboplastin Time |
| 11.2.7.Anti-Factor Xa |
| 11.2.8.Other Coagulation Tests |
| 11.3. Technology Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Optical |
| 11.3.2.Mechanical |
| 11.3.3.Electrochemical |
| 11.3.4.Others |
| 12. Competition Landscape |
| 12.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 12.2.1.F. Hoffmann-La Roche Ltd. |
| 12.2.2.Sysmex Corporation |
| 12.2.3.Abbott Laboratories |
| 12.2.4.Alere Inc. |
| 12.2.5.Nihon Kohden Corporation |
| 12.2.6.Siemens Healthineers |
| 12.2.7.Grifols S.A |
| 12.2.8.Beckman Coulter, Inc. |
| 13. Research Methodology |
| 14. Appendix and Abbreviations |
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.